Chinese Clinical Oncology

7.0k citations
826 papers · · active since 1950

Impact in

  • Oncology top 10%
    • Pancreatic and Hepatic Oncology Research
    • Cancer Immunotherapy and Biomarkers
    • Cancer-related molecular mechanisms research
    • Cancer Genomics and Diagnostics

Papers in

    • Pancreatic and Hepatic Oncology Research 60
    • Lung Cancer Research Studies 39
    • Cancer Immunotherapy and Biomarkers 37
    • Hepatocellular Carcinoma Treatment and Prognosis 66

Chinese Clinical Oncology

699 papers receiving 6.7k citations

Peers

Chinese Clinical Oncology
Comparison fields: 5 of 138
  • Oncology 2.1k
  • Cancer Research 968
  • Hepatology 395
  • Otorhinolaryngology 210
  • Pulmonary and Respiratory Medicine 1.4k
Replace Radiology and Oncology with:
Radiology and Oncology Slovenia
Expert Opinion on Emerging Drugs United States
Współczesna Onkologia Poland
Journal of Pathology and Translational Medicine South Korea
Advances in Medical Sciences Poland
Biomedical Journal Taiwan
Analytical Cellular Pathology China
Surgical pathology clinics United States
World Journal of Clinical Oncology United States
The Journal of Medical Investigation Japan
Chinese Clinical Oncology relative to Radiology and Oncology Slovenia Radiology and Oncology's profile →
Citations per field
00.5×1.5×
Radiology and Oncology · 1×
Citations per year

Countries where authors publish in Chinese Clinical Oncology

Since Specialization
Citations

This map shows the geographic impact of research published in Chinese Clinical Oncology. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in Chinese Clinical Oncology with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chinese Clinical Oncology more than expected).

Fields of papers published in Chinese Clinical Oncology

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers published in Chinese Clinical Oncology. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in Chinese Clinical Oncology.

About Chinese Clinical Oncology

The 826 papers published in Chinese Clinical Oncology in the last decades have received a total of 7.0k indexed citations . Papers published in Chinese Clinical Oncology usually cover Oncology (298 papers), Hepatology (69 papers), Cancer Research (129 papers), Pulmonary and Respiratory Medicine (227 papers) and Pathology and Forensic Medicine (77 papers) specifically the topics of Hepatocellular Carcinoma Treatment and Prognosis (66 papers), Lung Cancer Treatments and Mutations (66 papers), Pancreatic and Hepatic Oncology Research (60 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (59 papers), Glioma Diagnosis and Treatment (40 papers), Lung Cancer Research Studies (39 papers), Cancer Immunotherapy and Biomarkers (37 papers) and Gastric Cancer Management and Outcomes (36 papers). The most active scholars publishing in Chinese Clinical Oncology are Yun Shin Chun, Geoffrey Y. Ku, Andrew Lee, Tomoharu Sugie, Lorena Marcano-Bonilla, Lewis R. Roberts, Ghassan K. Abou‐Alfa, Kah-Whye Peng, Luke Russell and Peter J. Allen.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore journals with similar magnitude of impact